Expand DRUG Menu
DRUG MENU

DRUG Stock Posts


DRUG stock declines -45.8% in premarket,

Premarket Decliner

DRUG Bright Minds Biosciences54.98-1.71-3.0%

Premarket:29.81-25.17 (-45.8%)

Bright Minds Biosciences Provides Update About Planned Study with BMB-101 in Developmental and Epileptic Encephalopathies

Globe NewswireMon, 2-Nov 7:30 AM
DRUG stock increases 7.3% after hours.

After Hours Gainer

DRUG Bright Minds Biosciences80.01-3.45-4.1%

After Hours:85.86+5.85 (+7.3%)

Bright Minds to Announce Topline Results for BMB-101 Phase 2 Trial in Absence Seizures and Developmental and Epileptic Encephalopathies on Tuesday, January 6, 2026

Globe NewswireMon, 5-Jan 4:30 PM
DRUG stock declines -24.5% in premarket,

Premarket Decliner

DRUG Bright Minds Biosciences2.16+0.91+72.8%

Premarket:1.63-0.53 (-24.5%)

Bright Minds Announces Overnight Marketed Offering of Units

Globe NewswireMon, 22-Aug 7:05 PM
Load Earlier Posts
Market Data Delayed 15 Minutes